1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-139.30%
Negative net income growth while CSIQ stands at 63.33%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-6.46%
Negative yoy D&A while CSIQ is 100.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-107.64%
Negative yoy deferred tax while CSIQ stands at 100.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-15.71%
Both cut yoy SBC, with CSIQ at -100.00%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-1169.37%
Negative yoy working capital usage while CSIQ is 100.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
12.71%
AR growth while CSIQ is negative at -100.00%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-112.01%
Both reduce yoy inventory, with CSIQ at -100.00%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-216.63%
Both negative yoy AP, with CSIQ at -100.00%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
105.80%
Growth well above CSIQ's 100.00%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-88.20%
Both negative yoy, with CSIQ at -41.08%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-7700.65%
Negative yoy CFO while CSIQ is 100.00%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
50.39%
Some CapEx rise while CSIQ is negative at -100.00%. John Neff would see competitor possibly building capacity while we hold back expansions.
-100.00%
Both yoy lines negative, with CSIQ at -100.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-100.00%
Both yoy lines negative, with CSIQ at -100.00%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We reduce yoy other investing while CSIQ is 100.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
187.66%
We have mild expansions while CSIQ is negative at -100.00%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-172.74%
We cut debt repayment yoy while CSIQ is 100.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
-661.45%
We cut yoy buybacks while CSIQ is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.